Does viscous fibre supplementation influence glycaemic control in type 2 diabetes?

  • Jovanovski E & al.
  • Diabetes Care
  • 7 Jan 2019

  • curated by Sarfaroj Khan
  • UK Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Viscous fibre supplementation improves conventional markers of glycaemic control beyond usual care in patients with type 2 diabetes.

Why this matters

  • Evidence from previous randomised controlled trials (RCTs) suggests that viscous dietary fibre may offer beneficial effects on glycaemic control and improves cardiovascular disease risk profile.

Study design

  • Meta-analysis of 28 RCTs ≥3 weeks in duration involving 1394 patients with type 2 diabetes, identified after a search across electronic database.
  • Funding: None disclosed.

Key results

  • Compared with control and in addition to standard of care, median dose (~13.1 g/day) of viscous fibre significantly reduced:
    • HbA1c level (mean difference [MD], −0.58%; P=.0002; I2, 91%),
    • fasting blood glucose (MD, −0.82 mmol/L; P=.001; I2, 92%) and
    • homeostatic model assessment-insulin resistance (HOMA-IR; MD, −1.89; P=.02; I2, 94%).
  • Viscous fibre supplementation did not show any effect on fasting insulin (MD, −17.56 pmol/L; P=.08; I2, 90%) and fructosamine (MD, −0.12 pmol/L; P=.37) vs control group.
  • The certainty of evidence was moderate for HbA1c, fasting glucose, fasting insulin and HOMA-IR and was low for fructosamine.

Limitations

  • Heterogeneity among included studies.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit